Cargando…

Plasminogen and fibrinogen plasma levels in coronary artery disease

OBJECTIVE: The formation of thrombi at the site of atherosclerotic lesions plays a central role in atherothrombosis. Impaired fibrinolysis may exacerbate pre-existing coronary artery disease and potentiate its evolution. While the fibrinogen plasma level has been strongly associated with the severit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Luciana Moreira, Carvalho, Maria das Graças, Sousa, Marinez de Oliveira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Hematologia e Hemoterapia 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460410/ https://www.ncbi.nlm.nih.gov/pubmed/23049444 http://dx.doi.org/10.5581/1516-8484.20120075

Ejemplares similares

Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Kazmi, Rashid S., et al.
Publicado: (2012)

Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease
por: Fernandes, Adriano Basques, et al.
Publicado: (2015)

Relation between admission plasma fibrinogen levels and mortality in Chinese patients with coronary artery disease
por: Peng, Yong, et al.
Publicado: (2016)

Plasma levels of thrombomodulin, plasminogen activator inhibitor-1 and fibrinogen in elderly, diabetic patients with depressive symptoms
por: Gorska-Ciebiada, Malgorzata, et al.
Publicado: (2015)

Can Plasma Fibrinogen Levels Predict Bleeding After Coronary Artery Bypass Grafting?
por: Jalali, Alireza, et al.
Publicado: (2014)

Plasma Fibrinogen Concentration in Occlusive Arterial Disease
por: Ingram, G. I. C.
Publicado: (1952)

Serum Level of Plasminogen Activator Inhibitor Type-1 in Addicted Patients with Coronary Artery Disease
por: Forood, Afsaneh, et al.
Publicado: (2014)

Fibrinogen Activates the Capture of Human Plasminogen by Staphylococcal Fibronectin-Binding Proteins
por: Herman-Bausier, Philippe, et al.
Publicado: (2017)

Evaluation of Plasma Fibrinogen Levels before and after Coronary Artery Bypass Graft Surgery and Its Association with the Need for Blood Products
por: Honarmand, Azim, et al.
Publicado: (2022)

Assessment of the relationship between plasma fibrinogen-to-albumin ratio and slow coronary flow phenomenon in patients without obstructive coronary artery disease
por: Yang, Shao-bing, et al.
Publicado: (2023)

Plasma Fibrinogen Levels as an Indicator of Myocardial Necrosis
por: Cristal, N., et al.
Publicado: (1982)

Evaluation of Serum Fibrinogen, Plasminogen, α2-Anti-Plasmin, and Plasminogen Activator Inhibitor Levels (PAI) and Their Correlation with Presence of Retinopathy in Patients with Type 1 DM
por: Polat, Sefika Burcak, et al.
Publicado: (2014)

Biochemical and histological evidence of deteriorated bioprosthetic valve leaflets: the accumulation of fibrinogen and plasminogen
por: Sakaue, Tomohisa, et al.
Publicado: (2018)

Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease
por: Liu, Shuo-Lin, et al.
Publicado: (2020)

Fibrinogen is Associated with Clinical Adverse Events in Patients with Psoriasis and Coronary Artery Disease
por: Zhao, Lin, et al.
Publicado: (2023)

Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyser
por: Okuda, Masahiro, et al.
Publicado: (2003)

502 Plasminogen Activator Inhibitor-1, Fibrinogen and Lung Function in Adolescents with Asthma and Obesity
por: Huang, Fengyang
Publicado: (2012)

Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass Use
por: Gozdzik, Waldemar, et al.
Publicado: (2014)

Comparative prognostic value of C-reactive protein & fibrinogen in patients with coronary artery disease
por: Ndrepepa, Gjin, et al.
Publicado: (2014)

The Fibrinogen-to-Albumin Ratio Is Associated With Outcomes in Patients With Coronary Artery Disease Who Underwent Percutaneous Coronary Intervention
por: Zhang, Da-Peng, et al.
Publicado: (2020)

Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome
por: Duan, Zhenzhen, et al.
Publicado: (2021)

Prognostic value of fibrinogen-to-albumin ratio combined with coronary calcification score in patients with suspected coronary artery disease
por: Tian, Xin-Xin, et al.
Publicado: (2023)

Plasma Fibrinogen Levels and Cardiovascular Risk Factors in Japanese Schoolchildren
por: Fujii, Chie, et al.
Publicado: (2006)

Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease
por: Falcone, Colomba, et al.
Publicado: (2013)

Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study
por: Rahe-Meyer, N., et al.
Publicado: (2009)

The Sustained Increase of Plasma Fibrinogen During Ischemic Stroke Predicts Worse Outcome Independently of Baseline Fibrinogen Level
por: Swarowska, Marta, et al.
Publicado: (2014)

Blood fibrinogen level as a biomarker of adverse outcomes in patients with coronary artery disease: A systematic review and meta-analysis
por: Cui, Zhanqian, et al.
Publicado: (2022)

Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate
por: Collins, P. W., et al.
Publicado: (2014)

Peripheral Arterial Disease in Type 2 Diabetes Is Associated with an Increase in Fibrinogen Levels
por: Chen, Qin-Fen, et al.
Publicado: (2018)

Association of Fibrinogen with Severity of Stable Coronary Artery Disease in Patients with Type 2 Diabetic Mellitus
por: Hong, Li-Feng, et al.
Publicado: (2014)

Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
por: Bronić, Ana, et al.
Publicado: (2021)

The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer’s Disease
por: Fan, Dong-Yu, et al.
Publicado: (2021)

Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
por: Eapen, Danny J., et al.
Publicado: (2014)

Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Publicado: (2015)

Soluble Urokinase‐Type Plasminogen Activator Receptor and High‐Sensitivity Troponin Levels Predict Outcomes in Nonobstructive Coronary Artery Disease
por: Al‐Badri, Ahmed, et al.
Publicado: (2020)

Correlation between plasma renalase level and coronary artery disease
por: He, Benhong, et al.
Publicado: (2014)

Plasma interleukin-27 levels in patients with coronary artery disease
por: Miura, Kotaro, et al.
Publicado: (2017)

High Plasma Levels of Fortilin in Patients with Coronary Artery Disease
por: Aoyama, Masayuki, et al.
Publicado: (2022)

Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients
por: Huang, Yuli, et al.
Publicado: (2017)

Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis
por: Lin, Bowen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lfoetovro0863rs69sve3v7ruq